Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Fate Therapeutics Inc (NASDAQ: FATE) closed at $1.17 in the last session, down -10.00% from day before closing price of $1.3. In other words, the price has decreased by -$10.00 from its previous closing price. On the day, 1.68 million shares were traded. FATE stock price reached its highest trading level at $1.3349 during the session, while it also had its lowest trading level at $1.16.
Ratios:
We take a closer look at FATE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.27.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Wolchko J Scott bought 113,178 shares for $0.93 per share.
Bressi Jerome Charles sold 5,980 shares of FATE for $9,269 on Jan 10 ’25. The insiders now owns 270,203 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, TAHL CINDY, who serves as the insider of the company, sold 5,654 shares for $1.55 each. As a result, the insider received 8,764 and left with 336,707 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 134120608 and an Enterprise Value of -22972364. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.05 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -1.723 whereas that against EBITDA is 0.137.
Stock Price History:
The Beta on a monthly basis for FATE is 2.26, which has changed by -0.7804878 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $5.75, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -4.72%, while the 200-Day Moving Average is calculated to be -24.79%.
Shares Statistics:
According to the various share statistics, FATE traded on average about 1.81M shares per day over the past 3-months and 1555850 shares per day over the past 10 days. A total of 114.60M shares are outstanding, with a floating share count of 107.09M. Insiders hold about 6.58% of the company’s shares, while institutions hold 84.19% stake in the company. Shares short for FATE as of 1752537600 were 9460646 with a Short Ratio of 5.23, compared to 1749772800 on 9512319. Therefore, it implies a Short% of Shares Outstanding of 9460646 and a Short% of Float of 9.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
